CAMG Solamere Management’s Bristol-Myers Squibb BMY Stock Holding History

CAMG Solamere Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.61M	Buy	27,165 +6,363	+31%	+$419K	1.32%	29
2021 Q2	$1.39M	Sell	20,802 -139	-0.7%	-$9.06K	1.2%	35
2021 Q1	$1.32M	Sell	20,941 -765	-4%	-$47.6K	1.14%	36
2020 Q4	$1.34M	Sell	21,706 -10,332	-32%	-$635K	1.13%	32
2020 Q3	$1.93M	Sell	32,038 -1,979	-6%	-$119K	1.08%	28
2020 Q2	$2M	Sell	34,017 -24,975	-42%	-$1.49M	1.1%	31
2020 Q1	$3.29M	Sell	58,992 -23,019	-28%	-$1.41M	1.73%	16
2019 Q4	$5.27M	Buy	82,011 +3,576	+5%	+$205K	2.43%	12
2019 Q3	$3.98M	Sell	78,435 -7,629	-9%	-$359K	1.99%	18
2019 Q2	$3.9M	Buy	86,064 +16,117	+23%	+$751K	1.79%	24
2019 Q1	$3.34M	Buy	+69,947	New	+$3.48M	1.66%	30
2018 Q4	–	Sell	-5,478	Closed	-$336K	–	104
2018 Q3	$336K	Sell	5,478 -3,333	-38%	-$198K	0.17%	85
2018 Q2	$488K	Sell	8,811 -4,536	-34%	-$245K	0.24%	79
2018 Q1	$843K	Sell	13,347 -2,108	-14%	-$136K	0.38%	77
2017 Q4	$962K	Buy	15,455 +1,518	+11%	+$94.9K	0.43%	73
2017 Q3	$885K	Buy	13,937 +915	+7%	+$53.4K	0.44%	74
2017 Q2	$730K	Buy	13,022 +520	+4%	+$28.3K	0.42%	77
2017 Q1	$682K	Buy	12,502 +19	+0.2%	+$1.04K	0.4%	81
2016 Q4	$733K	Buy	+12,483	New	+$682K	0.52%	70

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

CAMG Solamere Management's BMY Position: Q3 2021 in Review

CAMG Solamere Management increased its Bristol-Myers Squibb (BMY) stake by 31% in Q3 2021, buying an estimated $419K and bringing the position to 27,165 shares worth $1.61M. The position accounts for 1.32% of the portfolio, ranked #29.

CAMG Solamere Management first reported a position in BMY in Q4 2016 and has held it in 19 quarters since. The position peaked at $5.27M in Q4 2019. 2,293 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

CAMG Solamere Management held 27,165 shares of Bristol-Myers Squibb worth $1.61M as of Q3 2021.
CAMG Solamere Management bought 6,363 Bristol-Myers Squibb shares in Q3 2021, an estimated $419K.
Bristol-Myers Squibb made up 1.32% of CAMG Solamere Management's portfolio in Q3 2021, its #29 holding.
CAMG Solamere Management first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 19 quarters since.
CAMG Solamere Management's Bristol-Myers Squibb position peaked at $5.27M in Q4 2019.
2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on CAMG Solamere Management's 13F filing for Q3 2021, filed 12 Nov 2021.